A Kornbluth1, D H Present, S Lichtiger, S Hanauer. Show Affiliations » 1. The Dr. Henry D. Janowitz Division of Gastroenterology, The Mount Sinai School of Medicine, New York, NY, USA.
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAnti-Inflammatory Agents/administration & dosageAnti-Inflammatory Agents/therapeutic useColitis, Ulcerative/drug therapyCyclosporine/administration & dosageCyclosporine/adverse effectsCyclosporine/bloodCyclosporine/therapeutic useDrug MonitoringFollow-Up StudiesGastrointestinal Agents/administration & dosageGastrointestinal Agents/adverse effectsGastrointestinal Agents/bloodGastrointestinal Agents/therapeutic useGlucocorticoids/administration & dosageGlucocorticoids/therapeutic useHumansImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/bloodImmunosuppressive Agents/therapeutic useInfusions, IntravenousLongitudinal StudiesMiddle AgedMonitoring, AmbulatoryPrednisone/administration & dosagePrednisone/therapeutic useTreatment Outcome
Substances: See more » Anti-Inflammatory AgentsGastrointestinal AgentsGlucocorticoidsImmunosuppressive AgentsCyclosporinePrednisone
Year: 1997 PMID: 9317057
Source DB: PubMed Journal: Am J Gastroenterol ISSN: 0002-9270 Impact factor: 10.864